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Summary
Background: Class II myosins generate contractile forces in
cells by polymerizing into bipolar filaments and pulling on
anchored actin filaments. Nonmuscle myosin II (NMII) plays
central roles during cell adhesion, migration, cytokinesis,
and tissue morphogenesis. NMII is present in virtually all
mammalian cell types as tissue-specific combinations of
NMIIA, NMIIB, and NMIIC isoforms. It remains poorly under-
stood how the highly dynamic NMII-actin contractile system
begins to assemble at new cellular locations during cell migra-
tion and how incorporation of different NMII isoforms into this
system is coordinated.
Results:Using platinum replica electronmicroscopy in combi-
nation with immunogold labeling, we demonstrate that individ-
ual activated (phosphorylated on the regulatory light chain
and unfolded) NMIIA and NMIIB molecules represent a func-
tional form of NMII in motile cells and that NMIIA and NMIIB
copolymerize into nascent bipolar filaments during contractile
system assembly. Using subdiffraction stimulated emission
depletion microscopy together with a pharmacological
block-and-release approach, we report that NMIIA and NMIIB
simultaneously incorporate into the cytoskeleton during initia-
tion of contractile system assembly, whereas the character-
istic rearward shift of NMIIB relative to NMIIA is established
later in the course of NMII turnover.
Conclusions: We show existence of activated NMII mono-
mers in cells, copolymerization of endogenous NMIIA and
NMIIB molecules, and contribution of both isoforms, rather
than only NMIIA, to early stages of the contractile system
assembly. These data change the current paradigms about
dynamics and functions of NMII and provide new conceptual
insights into the organization and dynamics of the ubiquitous
cellular machinery for contraction that acts in multiple cellular
contexts.
Introduction
Class II myosins are responsible for generation of contractile
forces in cells. The classic underlying mechanism of contrac-
tion involves polymerization ofmyosin II molecules into bipolar
filaments, which then pull on anchored actin filaments. Non-
muscle myosin II (NMII) is present in virtually all mammalian
cell types as tissue-specific combinations of NMIIA, NMIIB,
and NMIIC isoforms, which play both unique and overlapping
roles [1]. NMII is well known to play key roles in cell adhesion,*Correspondence: svitkina@sas.upenn.edumigration, cytokinesis, and tissue morphogenesis [1, 2]. Addi-
tionally, recent data increasingly point to unconventional
roles of NMII in membrane organelle morphogenesis, such
as exocytosis [3], endocytosis [4], post-Golgi and Golgi-to-
ER trafficking [5, 6], and mitochondrion fission [7].
NMII molecules (also referred here as NMII monomers)
consist of two heavy chains and two pairs of light chains.
NMII activity is regulated by phosphorylation of the myosin
regulatory light chain (MRLC). In the dephosphorylated state,
NMII monomers are inactive and have a folded autoinhibitory
conformation. When MRLC is monophosphorylated on Ser19
(pMRLC) or biphosphorylated on Thr18 and Ser19 (ppMRLC),
NMII molecules unfold, acquire motor activity [8], and can
polymerize into bipolar filaments [9]. Bipolar filaments can
then pull on and reorganize actin filaments, thus inducing as-
sembly of the contractile actin-NMII system, which consists
of interconnected actin-NMII bundles and networks associ-
ated with cell-matrix and cell-cell adhesions [10–12]. In motile
cells, the contractile system is highly dynamic and undergoes
constant assembly near the cell leading edge, followed by
disassembly in the cell body [11, 13] and recycling of inactive
NMII monomers back to the cell periphery [14]. However,
many questions remain about specifics of this cycle, espe-
cially at early stages of contractile system assembly, and
about commonalities and differences between NMII isoforms
in this process.
It is generally believed that bipolar NMII filaments are the
only functional form of NMII in cells. Their assembly occurs
in the distal lamellae of migrating cells behind lamellipodia
[11–13], a phenomenon thought to be the first event of the
NMII turnover cycle. However, we recently found that the
earliest stage of focal adhesion formation depends on NMII
activity in conditions where bipolar filaments are virtually ab-
sent and activated NMII monomers are abundant [10]. Such
conditions were created by treating REF52 fibroblasts with
blebbistatin, a specific inhibitor of NMII motor activity, and
then washing blebbistatin out. Blebbistatin treatment induced
depolymerization of NMII bipolar filaments without inhibiting
MRLC phosphorylation, thus generating a large pool of phos-
phorylated NMII monomers. Upon blebbistatin washout, when
these monomers regained motor activity, small focal adhe-
sions were formed before the formation of NMII bipolar fila-
ments, thus suggesting a role for activated NMII monomers
in adhesion initiation [10]. Since blebbistatin treatment and
washout likely synchronizes the formation of the contractile
system and nascent adhesions, a process that occurs sto-
chastically in lamellae in normal conditions, activated NMII
monomers might be present even in untreated cells, but direct
evidence for this idea is currently lacking.
In cells, NMIIB is often displaced toward the cell rear relative
to NMIIA [15, 16], which is thought to reflect incorporation
of NMIIB into preexisting structures made by NMIIA [17].
Such a model implies that NMIIA and NMIIB more likely form
homotypic filaments that sequentially incorporate into the
contractile system. However, existing data suggest that mus-
cle and nonmuscle myosins II can copolymerize in vitro [18],
truncated NMIIA and NMIIB proteins can heteropolymerize
in vitro [19] and in cells [20], and endogenous NMII isoforms
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explicit evidence for copolymerization of endogenous NMII
isoforms into heterotypic bipolar filaments is not available,
and the significance of such copolymerization, if it exists, is
not known.
In this study, we resolve key outstanding questions re-
garding the NMII turnover in motile cells. We provide direct
evidence that (1) activated NMIIA and NMIIB monomers repre-
sent a functional form of NMII in cells, (2) NMIIA and NMIIB
copolymerize in bipolar filaments, and (3) NMIIA and NMIIB
simultaneously incorporate into the cytoskeleton during initia-
tion of contractile system assembly, whereas the anterior-pos-
terior gradient of their localization is established much later,
likely in the course of bipolar filament recycling.
Results
Direct Evidence for the Existence of Activated Monomers
in Cells
Activated NMII monomers have been proposed to represent
functional species in cells and play a role in focal adhesion
initiation [10], secretion [22], and Golgi dynamics [23]. To
directly visualize activated NMII molecules in spreading
REF52 fibroblasts, we applied platinum replica electronmicro-
scopy (PREM) in combination with immunogold staining of
total MRLC, pMRLC, or ppMRLC (Figure 1; see also Figure S1
available online). To visualize morphology of immunogold-
labeled NMII species, we depleted actin filaments from deter-
gent-extracted cells by gelsolin treatment [24]. It has been
previously shown by correlative PREM of cells injected with
fluorescent myosin II that all discrete myosin structures visible
by fluorescence microscopy remain intact after detergent
extraction and gelsolin treatment [11, 12, 25]. The same proto-
col was used in this study. As expected, the majority of NMII
species were in the form of bipolar filaments, which formed
complex networks in the proximal lamella and cell body
(Figure 1A). Individual filaments could be observed primarily
near the leading edge. They had a dumbbell shape of 330 6
33 nm (mean6SD, n = 58) in total length and a bare-zonewidth
of 12 6 2 nm (all measurements include an w2–4 nm thick-
ness of platinum coating). The MRLC (Figure 1B), pMRLC
(Figure S1), and ppMRLC (Figure 1D) immunogold particles
marked ends of bipolar filaments consistent with the MRLC
position within the NMII motor domain. Unlabeled filament
ends were also occasionally observed, most likely because
of incomplete immunolabeling. In distal lamellae, bipolar fila-
ments were often present individually or in small assemblies,
such as stacks or networks. Some bipolar structures that
superficially looked like a single filament in fact represented
small stacks (Figure 1B). Distinction could be made based
on the number of bare zones. Whereas only one bare zone
was present in single filaments, two or more were seen in the
stacks (Figures 1B and 1D).
Importantly, we detected unfolded NMII monomers in distal
cell lamellae (Figures 1C, 1E, and S1). Their dimensions (1476
13 nm in length and 6 6 1 nm in width, mean 6 SD, n = 43),
which were similar to the dimensions of purified NMII mono-
mers [26], and the labeling pattern exhibiting MRLC, pMRLC,
or ppMRLC immunogold at one end of the molecule strongly
suggest that NMII molecules are unfolded and activated. In
MRLC-labeled samples, in addition to extended molecules,
we also observed compact gold-labeled structures (Figure 1C,
right), which could correspond to folded autoinhibited NMII
monomers associated with unphosphorylated MRLC [26].Although unfolded gold-labeled monomers were found with
roughly similar frequencies in pMRLC- and ppMRLC-stained
samples, it remains uncertain whether unfolded NMII mono-
mers are equally efficiently produced by mono- and biphos-
phorylation, because staining efficiencies of the pMRLC and
ppMRLC antibodies are likely different. The observed amount
of NMII monomers, folded or unfolded, detected in PREM
samples likely represented only a small fraction of their real
abundance in the cytoplasm. Indeed, we previously showed
biochemically that ppMRLC-positive NMII monomers could
form up to 50% of the entire population of NMII associated
with ppMRLC in these cells [10]. However, monomers are
more likely to be solubilized by detergent extraction than
NMII filaments or their assemblies are, because NMII mono-
mers have only two actin-binding sites compared with dozens
in bipolar NMII filaments [9] and because NMII motors spend
only a small fraction of time in an actin-bound state [2].
Together, these data provide direct evidence that unfolded
activated NMII monomers represent a bona fide NMII popula-
tion in cells and likely represent the first step of the NMII turn-
over cycle.
We found previously that under blebbistatin treatment,
bipolar filaments undergo disassembly [10], probably due to
release of tension, because increased tension conversely pro-
motes NMII polymerization [27]. Simultaneously, cells accu-
mulated activated NMII monomers [10]. Consistent with these
data, we found unfolded pMRLC- and ppMRLC-labeled NMII
monomers in blebbistatin-treated cells, as well as few remain-
ing bipolar filaments (Figure S1). These filaments, however,
often exhibited aberrant morphological features, probably re-
flecting intermediate stages of bipolar filament disassembly
(Figure S1). First, we detected a statistically significant
decrease (p = 0.0025, unpaired Student’s t test) in the average
length of NMII filaments in blebbistatin-treated cells (310 6
31 nm, mean 6 SD, n = 45) relative to that in untreated cells
(330 6 33 nm, n = 58). Second, the immunogold-labeled
head domains of bipolar filaments in blebbistatin-treated
cells were often splayed apart or unusually broadly distributed
along the filament length, whereas their bare zone was
frequently bent, associated with additional material, and
showed signs of splaying. Finally, we found unusual structures
that could be best described as ‘‘half-filaments,’’ because they
were gold labeled at only one pole and were about half as long
as normal filaments but their bare zone was too thick and the
gold-labeled pole too complex to represent single NMII mole-
cules (Figure S1E). The unlabeled end of these structures was
also often bulky, probably due to interaction with additional
proteins. We assume that these ‘‘half-filaments’’ could reflect
existence of a depolymerization mechanism that disentangles
NMII monomers in themiddle of a bipolar filament, for example
through binding of Mts1/S100A4 or phosphorylation of the
heavy-chain tail [28, 29]. Future studies should show whether
this speculation is viable.
Activated Monomers Comprise Both NMIIA and NMIIB
Isoforms
Since many cell types express a mixture of NMII heavy-chain
isoforms [1], we next asked which NMII isoform or isoforms
constitute the population of unfolded monomers in REF52
cells. Among three mammalian NMII isoforms, NMIIA and
NMIIB are broadly expressed, whereas NMIIC has restricted
expression [1]. Both NMIIA and NMIIB are expressed in
REF52 cells, but NMIIA was more visually abundant than
NMIIB, which could reflect a higher expression level of NMIIA
Figure 1. NMII Species Revealed by Immunogold PREM with MRLC Antibodies in Detergent-Extracted and Gelsolin-Treated REF52 Fibroblasts
(A) Overall distribution of NMII in REF52 cells. Boxed regions in the left panel are zoomed at right. Stacks of several NMII filaments are seen in both proximal
(region 1) and distal (region 2) lamellae; single NMII filaments (yellow arrowheads) are detected in distal lamella (region 2). A microtubule (white arrowhead)
and an intermediate filament (arrow) are marked in region 1.
(B and C) MRLC-labeled NMII species include bipolar filaments (B) and monomers (C). Gold particles (yellow) label heads of NMII filaments and monomers.
(B) NMII filaments form stacks of several (panels 1 and 2) or only two (panels 3 and 4) filaments, or exist as individual filaments (panels 5–7). The boxed region
in panel 4 is zoomed in the inset to show bare zones of two filaments.
(C) MRLC-labeled NMII monomers have an extended (left ten panels) or folded (right six panels) configuration. Tails of two criss-crossing NMII monomers in
the ninth panel are highlighted in magenta and green.
(D and E) NMII species labeled with ppMRLC immunogold (orange) include bipolar filaments (D) and unfolded NMII monomers (E). Last four panels in (D)
show single filaments.
Scale bars represent 5 mm (A, left panel), 200 nm (A, zoomed regions), and 100 nm (shown in B1; applies to all panels in B–E). See also Figure S1.
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Figure 2. NMII Monomers in REF52 Fibroblasts Comprise Both NMIIA and NMIIB Isoforms
Immunogold PREM of NMIIA (12 nm gold) and NMIIB (18 nm gold) reveals unfolded (first and third rows) and folded (second and fourth rows) NMII
monomers in the indicated experimental conditions. Gold particles associate with the tip of extended NMII tails, consistent with the antibody spec-
ificity for C termini of respective NMII isoforms. NMII heads can be occasionally recognized on the opposite end (yellow arrows). Our best interpre-
tation of the shape of NMII molecules is depicted by green pseudocolor, whereas associated material remains uncolored. Scale bar represents 50 nm
(applies to all panels).
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1961in these cells and/or greater efficiency of the NMIIA antibody.
Immunogold staining of gelsolin-treated cytoskeletons re-
vealed both NMIIA and NMIIB monomers, either compact or
extended, in untreated or blebbistatin-treated cells (Figure 2).
The lengths of extended NMIIA-labeled (143 6 15 nm, n = 62)
and NMIIB-labeled (1506 10 nm, n = 15) structures were indic-
ative of unfolded monomers. Since the isoform-specific anti-
bodies used in these experiments recognize the extreme
C-terminal region of NMII heavy chains, the position of gold
particles at the tip of thin, elongated structures was also
consistent with their identification as unfolded NMII mono-
mers. In favorable cases, two NMII motor domains (heads)
could be discerned at the unlabeled end of the molecule.
When heads were not clearly discernable, the unlabeled end
was still enlarged or appeared to be associated with other
structures (Figure 2). Additional material was also occasionally
observed along the NMII tail and probably corresponded to
some NMII interaction partners, the list of which is constantly
growing [6, 30–32]. As compared with preparations of purified
myosin II [26], heads were less clearly discernable in the gold-
labeled NMII monomers in cells. However, the narrow range of
length and thickness distributions of labeled structures, as
well as reproducible labeling at the tips, supports the idea
that these structures are extended NMII monomers. Compact
gold-labeled structures likely represented folded NMII mono-
mers, as suggested by their dimensions similar to those
observed in vitro [26]. These data show that unfolded mono-
mers of both NMIIA and NMIIB are present in cells.NMIIA and NMIIB Copolymerize into Heterotypic
Bipolar Filaments
A long-standing question in the field is whether different NMII
isoforms heteropolymerize in cells. To resolve this problem,
we performed double immunogold labeling of NMIIA and
NMIIB in spreading REF52 fibroblasts and human umbilical
vein endothelial cells (HUVECs) using secondary antibodies
conjugated with colloidal gold of different sizes (Figures 3
and S2). We found a significant fraction (w25%–40%, n =
348; see Table S1 for details) of individual bipolar filaments
simultaneously labeled with NMIIA and NMIIB antibodies,
indicating that NMIIA and NMIIB copolymerize in vivo. Individ-
ual filaments, which were carefully distinguished from small
parallel stacks, displayed gold labeling in the bare zone.
Thinner filaments that presumably contained fewer subunits
were labeled by few gold particles residing in the middle of
the bare zone, whereas thicker filaments that presumably con-
tained more subunits were labeled throughout the bare zone,
consistent with staggering of NMII molecules within filaments.
Parallel stacks of bipolar filaments also couldbe labeledbyone
or both sizes of immunogold (data not shown), indicating that
they contain NMII heteropolymers and/or a mixture of NMIIA
and NMIIB filaments. Bipolar filaments labeled with only one
size of immunogold, either NMIIA (w60%–75%) or NMIIB
(w2%),were alsoobserved (TableS1). Because the labeling ef-
ficiency is likely less than complete, a fraction of singly labeled
filamentsmight represent heteropolymers. These data demon-
strate that NMIIA and NMIIB naturally copolymerize in vivo.
Figure 3. Immunogold PREMReveals Heteropol-
ymers and Homopolymers of NMIIA and NMIIB
Isoforms in Cell Lamellae
NMIIA and NMIIB are labeled with 12 nm (yellow)
and 18 nm (blue) immunogold, respectively.
(A–C) NMII filaments in untreated cells (A), cells
treated with blebbistatin (B), and cells washed
out of blebbistatin for indicated periods of time
(C). Scale bar represents 100 nm (applies to all
panels in A–C).
(D) NMII filament lengths (including thickness of
platinum coating) in the indicated experimental
conditions. Filaments labeled with NMIIA anti-
body only (left panel) are shorter in blebbistatin-
treated cells than in other conditions. Filaments
containing NMIIB (right panel) have statistically
indistinguishable lengths in all conditions. Box
tops and bottoms indicate 75th and 25th quartiles,
respectively; whiskers encompass all data; the
dot is themean; and themiddle line is themedian.
*p < 0.0001 by unpaired Student’s t test; n is indi-
cated at the bottom of the plots.
See also Figure S2 and Table S1.
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decreased in the presence of blebbistatin, we tested whether
this response depends on the isoform composition of bipolar
filaments. For this analysis, we used cells treated with blebbis-
tatin and cells recovering from blebbistatin treatment for
different periods of time. Fewer NMII filaments were found in
blebbistatin-treated cells and cells washed out of blebbistatin
for only 1 min than in untreated cells or cells washed out of
blebbistatin for longer periods of time, consistent with our pre-
vious data [10]. We found that lengths of NMIIB-containing
filaments (NMIIA+NMIIB or NMIIB only) were statistically indis-
tinguishable across all conditions (Figure 3D, right). They were
also similar to the lengths of homotypic NMIIA filaments in
all conditions except for blebbistatin-treated cells, in whichNMIIA filaments were slightly but signif-
icantly shorter (Figure 3D, left). Since
NMIIA filaments represent the majority
of all NMII filaments, their length
changes could explain the decreased
average length of the total population
of NMII filaments in blebbistatin-treated
samples labeled with MRLC antibodies.
These results suggest that incorpora-
tion of NMIIB subunits could prevent
shortening of NMIIA filaments in the
presence of blebbistatin.
NMIIA and NMIIB Jointly Participate
in Initiation of Contractile System
Assembly
The presence of a substantial fraction of
NMIIB-containing bipolar filaments in
close proximity to the cell leading edge
was unexpected, because in polarized
cells NMIIB is typically displaced to-
ward the cell rear, whereas distal
lamellae in various cell types are mostly
populated by NMIIA [13, 16, 33]. Forma-
tion of this anterior-posterior NMIIA-
NMIIB gradient has been explained by
sequential incorporation of NMIIA andNMIIB isoforms into contractile structures [17]. An alternative
possibility suggests that both NMIIA and NMIIB can simulta-
neously begin polymerizing at the cell front and segregate
into anterior and posterior locations, respectively, during sub-
sequent turnover. To distinguish these possibilities, we took
advantage of the blebbistatin washout strategy, which syn-
chronizes the formation of the contractile system in cells
[10]. In blebbistatin-treated cells, total NMII depolymerizes
and becomes greatly enriched in membrane protrusions
(mostly ruffles), but following blebbistatin washout it leaves
protrusions and forms contractile structures in lamellae [10].
If NMIIA polymerizes first and NMIIB joins the NMIIA-formed
structures later, NMIIA should be enriched in the lamella
immediately after blebbistatin washout. If both NMII isoforms
Figure 4. NMIIA and NMIIB Have Similar Distribution in Lamella during Early Stages of Contractile System Assembly
(A) Wide-field immunofluorescence microscopy of REF52 cells triple stained with phalloidin (top row) and NMIIA and NMIIB antibodies (merged in bottom
row) in the indicated experimental conditions. The yellow boxes are the regions used for the representative linescans shown in (B). Scale bar represents
20 mm.
(B) Representative linescans of NMIIA (red) and NMIIB (blue) fluorescence intensities (y axis) across lamellipodium, lamella, and cell body regions (x axis) for
cells shown in (A). Dashed lines indicate lamellipodium-lamella (green) and lamella-cell body (purple) boundaries.
(C) Normalized average fluorescence intensities of NMIIA and NMIIB in lamellipodia (left) and lamellae (right) in different experimental conditions. Data are
represented as mean 6 SD. **p < 0.0001, *p < 0.01 by paired Student’s t test.
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1963polymerize simultaneously but become segregated at later
stages, however, the gradient formation will be delayed.
We fluorescently stained untreated, blebbistatin-treated,
and blebbistatin-washout cells with NMIIA and NMIIB anti-
bodies, as well as with phalloidin to detect actin filaments
(Figure 4). For this analysis, we used directly fixed cells (see
Experimental Procedures) to visualize both soluble and cyto-
skeleton-associated NMII populations. To quantitatively eval-
uate the relative abundance of NMIIA and NMIIB in distal cell
regions, we normalized the average fluorescence intensities
of NMIIA andNMIIB in lamellipodia and lamellae to the average
fluorescence intensity of the respective isoform in the cell
body, where both NMIIA and NMIIB are abundant. In untreated
cells, we found an expected distribution of NMIIA and NMIIBisoforms. Namely, both NMII isoforms had equally low levels
in lamellipodia, but NMIIA was more abundant in lamellae
thanNMIIB, consistent with the existence of an anterior-poste-
rior NMIIA-NMIIB gradient (53% 6 13% intensity for NMIIA
versus 35% 6 15% for NMIIB, p < 0.0001, paired Student’s
t test).
Consistent with the reported behavior of total NMII [10], both
NMIIA and NMIIB became enriched in ruffles of blebbistatin-
treated cells but decreased in this region following blebbistatin
washout (Figure 4C, left). Importantly, we found that in
lamellae of blebbistatin-treated cells or cells recovering from
blebbistatin for 1 or 5 min, NMIIB was more abundant than
NMIIA, and both NMII isoforms exhibited similar abundance
after 15 min washout (Figure 4C, right). The lack of NMIIA
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following blebbistatin washout indicated that the anterior-pos-
terior NMIIA-NMIIB gradient was not yet established during
this period of time, even though it existed in steady-state con-
ditions. These data suggest that NMIIA and NMIIB exhibit
similar behavior during early stages of the contractile system
assembly, rather than assembling sequentially.
The model of simultaneous assembly and subsequent
segregation of the NMIIA and NMIIB isoforms also predicts
that NMIIA/B copolymers should bemore abundant in lamellae
of cells recovering from blebbistatin than in lamellae of un-
treated cells at the steady state. To compare the degree of
NMIIA/B colocalization in untreated, blebbistatin-treated,
and blebbistatin-washout cells, we used stimulated emission
depletion (STED) microscopy (Figure 5), which can resolve
structures below the optical diffraction limit and is more suit-
able than PREM for quantification of large samples. Under
our STED imaging conditions, we achieved 70–80 nm resolu-
tion in the xy plane. To avoid interference from soluble NMII
pools, we used cells that were detergent-extracted prior to fix-
ation. To define subcellular domains, we also costained cells
with phalloidin and imaged F-actin distribution in the same
cells by confocal microscopy (Figure S3).
Consistent with wide-field fluorescence microscopy of non-
extracted cells, STED microscopy of extracted cells in normal
conditions revealed a prominent anterior-posterior gradient of
NMIIA and NMIIB, with the NMIIB distribution shifted toward
the cell center relative to NMIIA. Accordingly, high-magnifica-
tion STED images showed a greater overlap of the NMIIA and
NMIIB signals in the cell body as compared with the distal
lamella (Figure 5B). In the presence of blebbistatin, the overall
STED fluorescence signals for both NMII isoforms were very
low (Figure 5A) because of the increased solubility of NMII in
these conditions [10, 34], but an overlap of NMIIA and NMIIB
fluorescence could be seen among the remaining structures.
After 15 min blebbistatin washout, overall immunofluores-
cence intensities of NMIIA and NMIIB increased compared
with those of blebbistatin-treated cells, but their relative distri-
bution did not exhibit a prominent gradient as in untreated
cells. At high magnification, frequent overlaps of NMIIA and
NMIIB signals could be seen in lamellae and cell bodies.
To quantitatively evaluate proximity of NMIIA and NMIIB
immunofluorescence signals within the STED resolution limit,
we calculated correlation coefficients (r) for different cellular
regions in untreated cells, cells treated with blebbistatin,
and cells recovering from blebbistatin treatment for 15 min.
Correlation coefficients vary between 1 (complete colocaliza-
tion) and 21 (complementary distribution), where 0 indicates
random overlap. We found virtually no colocalization between
NMIIA andNMIIB in lamellipodia for all three experimental con-
ditions (Figure 5C), consistent with the idea that NMII species
in lamellipodia are monomers. In contrast, partial colocaliza-
tion between NMIIA and NMIIB was observed in the lamella
and cell body (Figure 5C). The overall magnitude of obtained
correlation coefficients (in the order of 0.1–0.4) was not high,
because the number of NMIIA-positive pixels greatly ex-
ceeded the number of NMIIB-positive pixels, which results in
an overall decrease of the correlation coefficient. Yet, the ob-
tained values were always significantly higher than the control
correlation coefficients for the same regions with one channel
rotated 90 (p < 0.0001, paired Student’s t test). Importantly,
the average correlation coefficient between NMIIA and NMIIB
localization in lamellae was significantly greater for blebbista-
tin-washout cells (r = 0.20 6 0.06) than for untreated cells(r = 0.126 0.06). These results suggest that when the contrac-
tile system assembles de novo from readily available pools of
NMIIA and NMIIB monomers, both isoforms exhibit similar
incorporation behavior into detergent-insoluble cytoskeleton.
Discussion
Here, we provide high-resolution characterization of endoge-
nous NMII species in their natural context in motile nonmuscle
cells and report several novel and unexpected features of NMII
organization and dynamics in cells. We have found that acti-
vated monomers of both NMIIA and NMIIB isoforms represent
an endogenous functional NMII species. This finding chal-
lenges the current paradigm wherein NMII bipolar filaments
are the only functional species of NMII. We also show that
NMIIA and NMIIB naturally copolymerize in cells and propose
that NMII copolymerization may affect the bipolar filament
properties. Finally, we report that NMIIA and NMIIB simulta-
neously incorporate into nascent contractile structures, sug-
gesting that they become segregated along the anterior-pos-
terior axis at late stages of the contractile system assembly
and turnover.
Roles of Activated NMII Monomers in Cells
Existence of activated NMII monomers in cells suggests that
unpolymerized NMII may play some roles in cell physiology,
such as focal adhesion initiation, lamellipodial protrusion
[10], and membrane organelle dynamics [22]. A compelling
mechanism to generate activated NMII monomers for this pur-
pose may rely on NMII heavy-chain regulation, because phos-
phorylation of the NMIIA [28] or NMIIB [29, 35] heavy chain, or
binding of Mts1/S100A4 to the NMIIA heavy chain [28], inhibits
NMII polymerization without inhibiting NMII motor activity.
Moreover, regulators of NMII polymerization at the heavy-
chain level are enriched in lamellipodia and affect protrusive
activity [35–38], thus supporting an idea that NMII monomers
are produced within lamellipodia and may provide traction
for lamellipodial protrusion by inducing nascent adhesions.
Activated NMII monomers can also account for unconven-
tional functions of NMII in membrane organelle dynamics
[3–7, 22, 30]. The role of NMII in these processes is often ex-
plained by contractile activity of bipolar filaments, which
form structures analogous to cytokinetic contractile rings.
However, the w300 nm-long NMII filaments are too large to
contract or constrict membrane organelles by such a mecha-
nism, because organelles are severalfold smaller than the bi-
polar filament length. In contrast, activated monomers appear
to be appropriate functional species of NMII to perform these
functions. Although NMII monomers are only 2-fold shorter
than bipolar filaments, they likely act by a totally different
mechanism from bipolar filaments, for example, by binding
actin filaments with the motor domain and using their tail
to bind another cargo, similar to unconventional myosins.
Consistent with this idea, monomeric NMIIA has been found
to associate via its C-terminal tail with lytic granules in natural
killer cells [22] and Golgi membranes isolated from intestinal
epithelium [23].
Heteropolymerization of NMIIA and NMIIB into
Bipolar Filaments
Despite repeated efforts to answer the question of whether
NMII isoforms heteropolymerize in vivo via biochemical or mo-
lecular biology approaches [19–21], the isoform composition
of endogenous bipolar NMII filaments has remained unknown.
Figure 5. Colocalization of NMIIA and NMIIB in Lamellae Is Greater at the Early Stage of Contractile System Assembly Than in Steady-State Conditions
(A) STED microscopy of cells in the indicated conditions stained with NMIIA and NMIIB antibodies. White outlines indicate cell boundaries based on phal-
loidin staining (see Figure S3). Yellow outlines are examples of regions used for determination of correlation coefficients in lamellipodia (Lp), lamellae (La),
and cell bodies (Body). Scale bar represents 10 mm.
(B) Square regions from lamellae and cell bodies of each cell (yellow boxes in A) are zoomed as separate channels (NMIIA and NMIIB) and merged images
(NMIIA+NMIIB). Correlation coefficient for NMIIA andNMIIB immunofluorescence (r) is indicated for each example onmerged panels. ‘‘Overlap’’ panels show
pixels exhibiting colocalization (white) of NMIIA and NMII signals that were thresholded to discard the lowest 5% intensity levels. Scale bar represents 2 mm.
(C) Average correlation coefficients for NMIIA andNMIIB immunofluorescence in lamellipodia, lamellae, and cell bodies for the sameexperimental conditions
as in (A). Box tops and bottoms indicate 75th and 25th quartiles, respectively; whiskers encompass all data; the dot is the mean; and the middle line is the
median. **p < 0.0001, *p < 0.01 by unpaired Student’s t test; the number of analyzed regions from 11–14 cells for each condition is indicated below the plot.
See also Figure S3.
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1966Our immunogold PREM data give an explicit answer to this
question by showing individual double-labeled NMIIA/NMIIB
bipolar filaments. While our manuscript was under review,
coassembly of overexpressed tagged NMII isoforms visual-
ized by subdiffraction fluorescence microscopy was reported
[39]. In this other study, coexpression of one NMII isoform with
a green tag on the head and another isoform with a red tag
on the tail produced green-red-green triplets of fluorescent
puncta, suggesting the formation of heterotypic NMII fila-
ments. However, at light-microscopy resolution, the triplets
could also correspond to closely aligned filament stacks
that are numerous in cells. In comparison, we visualized
endogenous bipolar filaments naturally formed in cells, rather
than those made of overexpressed truncated [19] or tagged
[39] NMII constructs, and used the high-resolution PREM
approach, which can reliably distinguish individual filaments
and stacks of parallel filaments.
The significance of NMII heteropolymerization is not fully
clear. It is interesting in this respect that the lengths of
homotypic NMIIA or NMIIB filaments assembled in vitro from
pure proteins [26] closely match the lengths of respective fila-
ments in blebbistatin-treated cells. However, in conditions al-
lowing NMII to exhibit actin-binding and motor activities, the
length of homotypic NMIIA filaments, but not NMIIB-contain-
ing filaments, increases. This observation can potentially be
explained by the existence of tension applied to NMII fila-
ments, because filaments in blebbistatin-treated cells, similar
to filaments assembled in vitro, are not under tension, in
contrast to filaments in untreated cells or cells recovering
from blebbistatin treatment. Therefore, it seems that NMIIA
filaments extend slightly under tension, whereas addition of
NMIIB subunits could stabilize the length of resulting hetero-
typic filaments.
Formation of the Anterior-Posterior NMIIA-NMIIB Gradient
Using acute induction of NMII polymerization, we found that
NMIIA and NMIIB simultaneously begin polymerizing at
the cell front and segregate into anterior and posterior loca-
tions, respectively, at later stages. These findings are consis-
tent with the recently reported decreased segregation of
NMII isoforms in freshly plated cells, as compared with fully
polarized cells [39], because spreading cells also exhibit de
novo contractile system assembly. Both sets of data, however,
contrast with the previously proposed model of sequential as-
sembly of NMII isoforms, where NMIIB joins relatively mature
structures premade by NMIIA [17]. One possibility for this
discrepancy is that early incorporation of NMIIB into nascent
structures might be difficult to detect by fluorescence micro-
scopy of live cells in the presence of soluble NMII pools [17].
It is also possible that the extraction procedure used in our ex-
periments removes not only the soluble pool of NMII but also a
fraction of the cytoskeletal pool. In this case, NMIIA and NMIIB
could be unevenly extracted from the samples [34], thus
altering the proportion of the two isoforms compared with
live cells. However, since we compare only relative amounts
of NMIIA and NMIIB in different experimental conditions (con-
trol cells, blebbistatin-treated cells, and blebbistatin-washout
cells), the potentially lost fraction should be the same for
NMIIA and NMIIB. Therefore, if a difference between samples
exists after extraction, it should have existed in live cells.
One possibility for how the anterior-posterior NMIIA-NMIIB
gradient can form at a slow rate following initial assembly of
the contractile system is via different rates of bipolar filament
recycling. Indeed, fluorescence recovery after photobleachingrevealed a slower turnover rate and a smaller mobile fraction
of NMIIB compared with NMIIA [34, 40]. It is not clear at pre-
sent whether the fast NMIIA turnover reflects preferential
disassembly of homotypic NMIIA filaments or preferential
extraction of NMIIA subunits from heterotypic filaments.
Regardless of the exact mechanism, slow recycling of NMIIB
suggests that even if NMIIA and NMIIB are similarly distributed
along the cell radius at starting conditions, polymeric NMIIB
stays bound to the actin cytoskeleton longer than NMIIA and
moves rearward with retrograde flow to eventually accumulate
in the cell body. Simultaneously, this process is expected to
cause depletion of the soluble pool of NMIIB monomers. In
contrast, more dynamic NMIIA can quickly repopulate newly
formed cellular regions and thus has more even distribution
throughout the cell.
Since NMIIB, like NMIIA, begins its turnover cycle at the
leading edge, NMIIB may have specific functions at the cell
front, not only at the cell rear as previously thought. For
example, NMIIB may support lamellipodial protrusion. Indeed,
NMIIB has been reported to localize to lamellipodia [16, 33, 41],
whereas deficiency in NMIIB results in prominent impairment
of lamellipodial protrusion [42–45]. Our data suggest that
NMIIB may support lamellipodia in a monomeric form, thus
providing a new framework to rethink and properly interpret
existing data on this point.
In conclusion, we propose a model wherein both NMIIA and
NMIIB begin their turnover cycle at the leading edge as acti-
vated monomers; they then assemble equally efficiently into
homo- and heterotypic filaments, which jointly participate in
the formation of nascent contractile networks and bundles.
At later stages of contractile system development, NMIIA
and NMIIB isoforms become sorted into anterior and posterior
locations, probably because of different turnover rates of
NMIIA and NMIIB subunits. Together, our data provide new
conceptual insights into the organization and dynamics of
the ubiquitous cellular machinery for force generation, which




Working concentrations of blebbistatin (Toronto Research Chemicals) were
prepared from 10 mM stock in DMSO. The following primary antibodies
were used: mouse monoclonal antibodies to MRLC (Sigma #M4401), NMIIA
(Abcam #ab55456), and NMIIB (Iowa Hybridoma Bank #CMII 23, for Fig-
ure S2); rabbit polyclonal antibodies to pMRLC (Ser19 phospho-myosin
light chain 2, Cell Signaling #3671), ppMRLC (Thr18/Ser19 phospho-myosin
light chain 2, Cell Signaling #3674), NMIIA (BTI #BT-567, for Figure S2), and
NMIIB (Cell Signaling #3404). The following secondary anti-mouse and anti-
rabbit antibodies were used: 12 nm and 18 nm colloidal gold-conjugated
antibodies (Jackson ImmunoResearch) for immunoelectron microscopy,
Alexa Fluor 488 and Alexa Fluor 594 (Molecular Probes) for wide-field fluo-
rescence microscopy, and Atto 425 (Rockland Immunochemicals) and
DyLight 488 (Thermo Scientific) for STEDmicroscopy. Alexa Fluor 680 phal-
loidin was from Molecular Probes.
Cell Culture and Drug Treatments
REF52 rat embryo fibroblasts [12] were cultured in DMEM (Gibco) supple-
mented with 10% fetal bovine serum (Gibco) and penicillin/streptomycin
at 37C and 5%CO2. For experiments, cells were plated on glass coverslips
and allowed to spread for 3 hr. HUVECs (Lonza) weremaintained in endothe-
lial cell basal medium (Lonza) and cultured for six passages maximum. For
experiments, HUVECswere plated on collagen-coated coverslips applied at
an approximate concentration of 5 mg/cm2 (BD Biosciences). For blebbista-
tin treatment experiments, blebbistatin was added to cell cultures 3 hr
after plating at a final concentration of 100 mM, and cells were incubated
for additional 1 hr. For washout experiments, after 1 hr incubation with
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1967blebbistatin, cells were transferred to fresh blebbistatin-free medium, incu-
bated for various periods of time, and fixed.
Platinum Replica Electron Microscopy
Detailed procedures for PREM, gelsolin treatment, and immunogold stain-
ing have been described previously [24, 46–48]. Briefly, cells were rinsed
quickly with PBS, extracted for 2–3 min at room temperature with 1% Triton
X-100 in PEM buffer (100 mM PIPES-KOH [pH 6.9], 1 mM MgCl2, 1 mM
EGTA) containing 2 mM paclitaxel (Sigma) and PhosSTOP (Roche) at the
manufacturer’s recommended concentration (one tablet per 10 ml). Pacli-
taxel and PhosSTOP were also added at all subsequent steps before fixa-
tion. After three quick rinses with PEM buffer, detergent-extracted cells
were incubated with 0.4 mg/ml full-length gelsolin (gift of A. Weber, Univer-
sity of Pennsylvania) in G buffer (50 mM MES-KOH [pH 6.3], 0.1 mM CaCl2,
2 mMMgCl2, 0.5 mM dithiothreitol) for 15 min at room temperature. After an
additional rinse with PEM buffer, samples were incubated with primary an-
tibodies in PEM buffer for 30 min. For pMRLC or ppMRLC staining, primary
antibodies were added to gelsolin solution. Samples were rinsed twice in
PEM, incubated in the third change of PEM for 15 min, and fixed with
0.2% glutaraldehyde in 0.1 M cacodylate buffer for 20 min. Samples were
quenched with NaBH4 in PBS, incubated overnight with secondary gold-
conjugated antibodies, and fixed with 2% glutaraldehyde. For PREM, sam-
ples were then fixed with tannic acid and uranyl acetate, critical point dried,
coated with platinum and carbon, transferred onto electron microscopic
grids, and analyzed using JEM 1011 transmission EM (JEOL USA) operated
at 100 kV. Images were captured with an ORIUS 832.10W CCD camera
(Gatan) and are presented in inverted contrast. Gold particles in PREM sam-
ples were identified at 200,0003 magnification after contrast enhancement
to distinguish them from other bright objects. Gold particles were pseudo-
colored using the Adobe Photoshop brush tool with 50% opacity. Color
labeling of other structures of interest was performed using the Adobe Pho-
toshop hue/saturation tool to avoid obscuring structural details.
Fluorescence Microscopy
For immunofluorescence staining, cells were rinsed quickly with PBS and
either directly fixed for 15 min with 4% formaldehyde in PBS or pre-ex-
tracted for 2–3 min with 1% Triton X-100 in PEM buffer containing 2% poly-
ethelene glycol (35,000 kDa) and 2 mM unlabeled phalloidin. Directly fixed
samples were permeabilized with 0.1% Triton X-100 in PBS and stained
with primary and secondary antibodies. Alexa Fluor 488- and Alexa Fluor
594-conjugated secondary antibodies were used for wide-fieldmicroscopy.
For STED microscopy, detergent-extracted cells were fixed and incubated
with the mouse NMIIA and rabbit NMIIB primary antibodies followed by the
addition of secondary Atto 425 goat anti-mouse and DyLight 488 goat anti-
rabbit antibodies. For costaining of F-actin, fluorescently labeled phalloidin
was added to the secondary antibody solution. Coverslips were extensively
washed with PBS and mounted with ProLong Gold antifade reagent
(Invitrogen).
Wide-field fluorescence microscopy was performed using an Eclipse
TE2000-U inverted microscope (Nikon) equipped with a Plan Apo 1003
1.3 NA objective and Cascade 512B CCD camera (Photometrics) driven
by MetaMorph imaging software (Molecular Devices). STED images were
collected with a Leica SP5 STED CW microscope using sequential acquisi-
tion mode and the following excitation lasers: 458 nm and 514 nm for STED;
633 nm for confocal imaging. The depletion laser (592 nm)was used at 100%
power to obtain maximum STED resolution, which was between 70 and
80 nm. Images shown were not deconvolved. Slides were analyzed in a
blinded fashion.
Image Analyses
Dimensions in PREM images were determined using Adobe Photoshop. All
presented measurements include the thickness of platinum coating
(w2 nm). Since the thickness of coating can vary depending on the z posi-
tion of the structure, the actual structure dimensions are estimated to be
2–4 nm smaller. Immunogold-labeled structures were measured together
with the gold particles, when they were localized at the tip of the structure.
Determination of relative enrichment of NMIIA and NMIIB in different
cellular regions was performed using wide-field fluorescence images of
cells directly fixed with formaldehyde and triple stained with NMIIA and
NMIIB antibodies and phalloidin. The linescan tool in MetaMorph was
used to obtain fluorescence intensity profiles from background-subtracted
images along 3 mm-wide lines drawn perpendicular to the cell edge and
crossing the lamellipodium, lamella, and cell body (perinuclear region).
The lamellipodium-lamella and lamella-body boundaries were manuallyassigned based on the phalloidin channel (lamellipodium-lamella) or the
levels of NMII fluorescence approaching a plateau (lamella-cell body). The
average intensities of NMIIA and NMIIB in the lamellipodium, lamella, and
cell body were calculated using corresponding segments of the intensity
profile and expressed as a percentage of the average intensity of the
respective NMII isoform signal in the cell body. Data were averaged from
20–25 profiles from 11–17 cells for each condition.
Determination of colocalization of NMIIA and NMIIB in different cellular
regions was performed using single-plane STED images. Correlation coeffi-
cients for NMIIA and NMIIB immunofluorescence signals were calculated
for background-subtracted regions of interest using the correlation plot
tool in MetaMorph. Square 6 3 6 mm regions of interest were selected in
lamellae and the cell body; irregularly shaped regions of approximately
the same area were outlined in lamellipodia based on phalloidin staining.
Regions of interest were selected from 11–14 cells for each condition. Sta-
tistical significance of correlation coefficients for square regions in lamellae
and cell bodies was determined relative to correlation coefficients for the
same regions with one channel rotated 90. The correlation coefficient for
rotated images was invariably close to zero (random overlap) for all cell
regions and treatment conditions. Statistical analyses were performed
using Microsoft Excel or GraphPad InStat software packages.
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